Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy

Overview of attention for article published in Journal for Immunotherapy of Cancer, March 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

So far, Altmetric has seen 17 X posts from 7 X users, with an upper bound of 35,625 followers.

RT @sitcancer: #JITC Research: Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy https://…

#JITC Research: Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy https://t.co/WxjuAGYrjE https://t.co/qHNqk8bU6Y

#JITC Research: Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy https://t.co/WxjuAGYrjE https://t.co/mtEpLAp1Ce

RT @sitcancer: #JITC Research: Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy https://…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 13 additional X posts.